Release Date: 01/11/11 08:22 Summary: Quarterly Activities and Cashflow Report - September 2011 Price Sensitive: Yes Download Document 1.89MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%